A new home-testing kit to diagnose AMD has been launched by Optegra Eyecare, enabling men and women in the UK to identify their own personal risk factor of contracting AMD.
Optegra, which is working with Asper Biotech, explained that its £399 Genetic Testing Service kit requires patients to give a small saliva sample and the completed test is posted back to the Optegra Eye Hospital in Guildford for analysis.
Patients are offered a free AMD counselling service where specific steps are identified to give the patient the best possible protection against AMD. A full patient report with the test results is also provided.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
